ATE349420T1 - Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung - Google Patents

Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung

Info

Publication number
ATE349420T1
ATE349420T1 AT96940538T AT96940538T ATE349420T1 AT E349420 T1 ATE349420 T1 AT E349420T1 AT 96940538 T AT96940538 T AT 96940538T AT 96940538 T AT96940538 T AT 96940538T AT E349420 T1 ATE349420 T1 AT E349420T1
Authority
AT
Austria
Prior art keywords
agents
radical species
present
azulenyl nitrones
production
Prior art date
Application number
AT96940538T
Other languages
English (en)
Inventor
David A Becker
Original Assignee
Florida Internat University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida Internat University filed Critical Florida Internat University
Application granted granted Critical
Publication of ATE349420T1 publication Critical patent/ATE349420T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/26All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/30Azulenes; Hydrogenated azulenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96940538T 1995-11-17 1996-11-15 Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung ATE349420T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US694995P 1995-11-17 1995-11-17
US2463196P 1996-08-27 1996-08-27

Publications (1)

Publication Number Publication Date
ATE349420T1 true ATE349420T1 (de) 2007-01-15

Family

ID=26676282

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940538T ATE349420T1 (de) 1995-11-17 1996-11-15 Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung

Country Status (8)

Country Link
US (3) US6083988A (de)
EP (1) EP0888290B1 (de)
JP (1) JP3887020B2 (de)
AT (1) ATE349420T1 (de)
AU (1) AU7739796A (de)
CA (1) CA2235765C (de)
DE (1) DE69636795D1 (de)
WO (1) WO1997019054A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021430A1 (de) * 1996-07-19 2000-07-26 Centaur Pharmaceuticals, Inc. Furan-nitronverbindungen
TW429241B (en) * 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives
MA26553A1 (fr) * 1997-10-17 2004-12-20 Centaur Pharmaceuticals Inc Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
JP2002509147A (ja) * 1998-01-16 2002-03-26 センター ファーマシューティカルズ, インコーポレイテッド チオフェンニトロン化合物
NZ505757A (en) * 1998-01-16 2002-09-27 Centaur Pharmaceuticals Inc Thioether furan nitrone compounds and pharmaceuticals thereof; useful for the treatment or prophylaxis of neurodegenerative, autoimmune and inflammatory conditions
FR2780404B1 (fr) * 1998-06-26 2001-04-13 Adir Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6569826B1 (en) 1999-10-19 2003-05-27 The Procter & Gamble Company Radical scavenger
US6566320B1 (en) 1999-10-19 2003-05-20 The Procter & Gamble Company Bleaching composition containing chromotropic compound
EP1094106A1 (de) * 1999-10-19 2001-04-25 The Procter & Gamble Company Reinigungsmittelzusammensetzung
GB0024938D0 (en) * 2000-10-11 2000-11-29 Queen Mary & Westfield College Method of diagnosis
WO2002065993A2 (en) 2001-01-08 2002-08-29 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US6746808B2 (en) 2001-08-29 2004-06-08 Fuji Xerox Co., Ltd. Image forming color toner, color image forming method and color image forming apparatus
US6762322B1 (en) * 2002-12-20 2004-07-13 Goodyear Tire & Rubber Company Preparation of nitrone derivatives
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
US7910729B2 (en) 2004-09-22 2011-03-22 The Florida International University Board Of Trustees Azulenyl nitrone spin trapping agents, methods of making and using same
GB0518890D0 (en) * 2005-09-15 2005-10-26 Ucl Biomedica Plc Method of determining damage to skin
WO2008002614A2 (en) * 2006-06-28 2008-01-03 The Florida International University Board Of Trustees Pseudoazulenyl nitrones
GB0623758D0 (en) * 2006-11-25 2007-01-10 Univ Salford The Free radical trapping
EP2242360B1 (de) * 2008-02-12 2015-04-08 Tosk, Inc. Doxorubicin-hilfsstoffe zur toxizitätsminderung und anwendungsverfahren dafür
US8313456B2 (en) * 2009-06-30 2012-11-20 Palo Alto Research Center Incorporated Drug-transfer device, drug-delivery system incorporating the same, methods of fabricating the same, and methods of enabling administration of a drug
US9034926B2 (en) 2010-12-30 2015-05-19 Nicholas V. Perricone Topical nitrone spin trap compositions for psoriasis
US9156862B2 (en) * 2011-11-01 2015-10-13 The Florida International University Board Of Trustees Silylated azulenyl nitrone spin traps as chromotropic superoxide detectors
GB201217228D0 (en) * 2012-09-26 2012-11-07 Pepric Nv Methods and systems for determining a particle distribution
WO2014151486A1 (en) * 2013-03-15 2014-09-25 The Florida International University Board Of Trustees Chromotropic detection of ionizing radiation
US10323147B1 (en) 2016-05-26 2019-06-18 Marathon Petroleum Company Lp Asphalt composition containing ester bottoms
US11814506B2 (en) 2019-07-02 2023-11-14 Marathon Petroleum Company Lp Modified asphalts with enhanced rheological properties and associated methods
CA3088894C (en) 2020-05-21 2024-04-30 Marathon Petroleum Company Lp Systems and methods for venting asphalt transport tanks

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35112A (en) * 1862-04-29 Improvement in head-rests for car-seats
US35213A (en) * 1862-05-13 Improved hydrant
US3509215A (en) * 1967-06-15 1970-04-28 Givaudan Corp Acyl indan compounds
US4141995A (en) * 1975-04-17 1979-02-27 Lilly Industries Limited Ketone derivatives
JPS5916867A (ja) * 1982-07-21 1984-01-28 Nippon Chemiphar Co Ltd 新規アズレン誘導体およびその製造法
US4990665A (en) * 1982-11-01 1991-02-05 Microsi, Inc. Diarylnitrones
JPS6197238A (ja) * 1984-10-17 1986-05-15 Ajinomoto Co Inc 新規アズレン誘導体およびその用途
JPS63239248A (ja) * 1986-11-07 1988-10-05 Ajinomoto Co Inc 抗脂血剤
US5025032A (en) 1989-10-17 1991-06-18 Oklahoma Medical Research Foundation Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage
EP0496796B1 (de) * 1989-10-17 1994-08-31 Oklahoma Medical Research Foundation Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten
USRE35213E (en) 1989-10-17 1996-04-16 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
US5235076A (en) * 1991-05-28 1993-08-10 University Of Hawaii Azulenic retinoid compounds, compositions and methods
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps

Also Published As

Publication number Publication date
JP3887020B2 (ja) 2007-02-28
EP0888290A4 (de) 2004-08-18
WO1997019054A1 (en) 1997-05-29
US6083988A (en) 2000-07-04
US6197825B1 (en) 2001-03-06
US6291702B1 (en) 2001-09-18
AU7739796A (en) 1997-06-11
EP0888290B1 (de) 2006-12-27
JP2000501081A (ja) 2000-02-02
EP0888290A1 (de) 1999-01-07
CA2235765C (en) 2006-04-04
DE69636795D1 (de) 2007-02-08
CA2235765A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
DE69636795D1 (de) Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung
DE69832209D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutyraldehyd durch Oxidation von 3,3-Dimethylbutanol
DE69532137D1 (de) Verbessertes verfahren zur stabilisierung biologischer substanzen während der trocknung und anschliessender lagerung sowie die entsprechenden zusammensetzungen
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
DE59504613D1 (de) Verfahren zur Herstellung von Aldehyden
DE69517771D1 (de) Propylen Blockcopolymer und Verfahren zu seiner Herstellung
DE69614940D1 (de) Ethylen-Copolymerkautschukzusammensetzung, vulkanisierbare Kautschukzusammensetzung, die den Copolymerkautschuk enthält und Verfahren zur Herstellung von Copolymerkautschuk
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE59407551D1 (de) Verfahren zur Herstellung von Triphenylphosphin
DE69524369D1 (de) Verfahren zur Extraktion von Karotenoiden aus Bakterienzellen
DE59503847D1 (de) Verfahren zur Herstellung von 3,5-Dimethylpyrazol-blockierten Polyisocyanaten
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DE59601745D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5-trimethylcyclohexylamin
DE59401009D1 (de) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluorpropan
DE69828191D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin
DE3873524D1 (de) Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel.
DE59502572D1 (de) Verfahren zur Herstellung von 2-Halogenpyridinaldehyden
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE69519203D1 (de) Verfahren zur Herstellung von Extrakten enthaltende polyphenalische oligomere Verbindungen von Catechin-Typ, aus pflanzenartigen Quellen, und diese erhaltene Extrakte
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE69401368D1 (de) Verfahren zur Herstellung von 1,4-Dicyano-2-buten
DE59305733D1 (de) Verfahren zur Herstellung von 1,3-Difluorbenzol
DE69701297D1 (de) Verfahren zur Herstellung des Oxims von Cyclododecanon durch Photonitrosation von Cyclododecan in Gegenwart von Trichlornitrosomethan
DE59600661D1 (de) Verfahren zur Herstellung von d,I-Menthol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties